News | August 26, 2025
Remedium Lifecare charts 4X growth strategy
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
The first pillar is advanced manufacturing, focused on upgrading existing CDMO
This acquisition expands HGM's healthcare platform capabilities in revenue cycle management
The PLI scheme focuses on incentivizing a strategic shift towards high-value, innovative products such as biologics, complex generics, and specialty formulations
The company’s virgin PET chips plant in Egypt, commissioned in Q4 FY25, achieved 74.8 per cent capacity utilization in its first full quarter. In India, the Panipat facility operated at 96.6 per cent utilization
The company reported revenue from operations at Rs. 6,573.7 crore, up 6 per cent YoY
Hikal has reported total income of Rs. 381.4 crores during the period ended June 30, 2025
Tamsulosin, an alpha-1 adrenergic receptor blocker, combined with Dutasteride, a dual 5- alpha-reductase inhibitor, is indicated for the treatment of moderate to severe symptoms of benign prostatic hyperplasia (BPH) in adult men
This is the group’s first NoC approval in Canada
Vasograin Plus represents a major advancement in the treatment of migraine
Fermenta now becomes one of the only two companies globally to hold a CEP for this variant of Vitamin D3
Subscribe To Our Newsletter & Stay Updated
